Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Caetano, Bráulia C.
Bruña-Romero, Oscar
Fux, Blima
Mendes, Erica A.
Penido, Marcus L. O.
and
Gazzinelli, Ricardo T.
2006.
Vaccination with Replication-Deficient Recombinant Adenoviruses Encoding the Main Surface Antigens ofToxoplasma gondiiInduces Immune Response and Protection Against Infection in Mice.
Human Gene Therapy,
Vol. 17,
Issue. 4,
p.
415.
Caetano, Braulia C.
Bruna-Romero, Oscar
Fux, Blima
Mendes, Erica A.
Penido, Marcus L. O.
and
Gazzinelli, Ricardo T.
2006.
Vaccination with Replication-Deficient Recombinant Adenoviruses Encoding the Main Surface Antigens of Toxoplasma gondii Induces Immune Response and Protection Against Infection in Mice.
Human Gene Therapy,
Vol. 0,
Issue. 0,
p.
060330070144001.
García-Hernández, E
González-Sánchez, J L
Andrade-Manzano, A
Contreras, M L
Padilla, S
Guzmán, C C
Jiménez, R
Reyes, L
Morosoli, G
Verde, M L
and
Rosales, R
2006.
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine.
Cancer Gene Therapy,
Vol. 13,
Issue. 6,
p.
592.
Gerdts, Volker
Mutwiri, George K.
Tikoo, Suresh K.
and
Babiuk, Lorne A.
2006.
Mucosal delivery of vaccines in domestic animals.
Veterinary Research,
Vol. 37,
Issue. 3,
p.
487.
INNES, E. A.
and
VERMEULEN, A. N.
2006.
Vaccination as a control strategy against the coccidial parasitesEimeria,ToxoplasmaandNeospora.
Parasitology,
Vol. 133,
Issue. S2,
p.
S145.
Schaap, D.
Vermeulen, A.N.
Roberts, C.W.
and
Alexander, J.
2007.
Toxoplasma Gondii.
p.
721.
Döşkaya, Mert
Kalantari-Dehaghi, Mina
Walsh, Craig M.
Hiszczyńska-Sawicka, Elżbieta
Davies, D. Huw
Felgner, Philip L.
Larsen, Liza S.Z.
Lathrop, Richard H.
Hatfield, G. Wesley
Schulz, Jessica R.
Gürüz, Yüksel
and
Jurnak, Frances
2007.
GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine.
Vaccine,
Vol. 25,
Issue. 10,
p.
1824.
CUI, Y.‐L.
HE, S.‐Y.
XUE, M.‐F.
ZHANG, J.
WANG, H.‐X.
and
YAO, Y.
2008.
Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co‐delivery of IL‐12 in mice.
Parasite Immunology,
Vol. 30,
Issue. 5,
p.
309.
Piña-Vázquez, Carolina
Saavedra, Rafael
and
Hérion, Pascal
2008.
A quantitative competitive PCR method to determine the parasite load in the brain of Toxoplasma gondii-infected mice.
Parasitology International,
Vol. 57,
Issue. 3,
p.
347.
Dlugonska, Henryka
and
Chauhan, Virander
2008.
Toxoplasma Rhoptries: Unique Secretory Organelles and Source of Promising Vaccine Proteins for Immunoprevention of Toxoplasmosis.
BioMed Research International,
Vol. 2008,
Issue. 1,
Liu, Quan
Gao, Shengyan
Jiang, Li
Shang, Limin
Men, Jingtao
Wang, Ze
Zhai, Yujia
Xia, Zhiping
Hu, Rongliang
Zhang, Xichen
and
Zhu, Xing-Quan
2008.
A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
Microbes and Infection,
Vol. 10,
Issue. 12-13,
p.
1355.
Garcia, João Luis
2009.
Vaccination concepts againstToxoplasma gondii.
Expert Review of Vaccines,
Vol. 8,
Issue. 2,
p.
215.
Jongert, Erik
Roberts, Craig W
Gargano, Nicola
Förster-Waldl, Elisabeth
and
Petersen, Eskild
2009.
Vaccines against Toxoplasma gondii: challenges and opportunities.
Memórias do Instituto Oswaldo Cruz,
Vol. 104,
Issue. 2,
p.
252.
Kur, Józef
Holec-Gąsior, Lucyna
and
Hiszczyńska-Sawicka, Elżbieta
2009.
Current status of toxoplasmosis vaccine development.
Expert Review of Vaccines,
Vol. 8,
Issue. 6,
p.
791.
Fernández-Robledo, José A.
and
Vasta, Gerardo R.
2010.
Production of recombinant proteins from protozoan parasites.
Trends in Parasitology,
Vol. 26,
Issue. 5,
p.
244.
Yuan, Zi-Guo
Zhang, Xiu-Xiang
He, Xian-Hui
Petersen, Eskild
Zhou, Dong-Hui
He, Yong
Lin, Rui-Qing
Li, Xiu-Zhen
Chen, Xu-Li
Shi, Xiao-Ru
Zhong, Xiu-Ling
Zhang, Bing
and
Zhu, Xing-Quan
2011.
Protective Immunity Induced by
Toxoplasma gondii
Rhoptry Protein 16 against Toxoplasmosis in Mice
.
Clinical and Vaccine Immunology,
Vol. 18,
Issue. 1,
p.
119.
Zhao, Guanghui
Zhou, Aihua
Lu, Gang
Meng, Min
Sun, Min
Bai, Yang
Han, Yali
Wang, Lin
Zhou, Huaiyu
Cong, Hua
Zhao, Qunli
Zhu, Xing-Quan
and
He, Shenyi
2013.
Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis.
Parasites & Vectors,
Vol. 6,
Issue. 1,
Roberts, Craig W.
McLeod, Rima
Henriquez, Fiona L.
and
Alexander, James
2014.
Toxoplasma Gondii.
p.
995.
Sánchez-Sampedro, Lucas
Perdiguero, Beatriz
Mejías-Pérez, Ernesto
García-Arriaza, Juan
Di Pilato, Mauro
and
Esteban, Mariano
2015.
The Evolution of Poxvirus Vaccines.
Viruses,
Vol. 7,
Issue. 4,
p.
1726.
Zhao, Guanghui
Song, Xiaojie
Kong, Xiangnan
Zhang, Ning
Qu, Shaoling
Zhu, Wei
Yang, Yanyan
and
Wang, Qian
2017.
Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice.
Acta Tropica,
Vol. 171,
Issue. ,
p.
17.